The bottom line re Metformin Metformin shows promise for extending healthspan by preventing diseases like diabetes, heart disease, and dementia
Based on researchers' studies on the skin, Glutathione performs several activities in our body such as building and repairing skin tissues
Side effects tend to mirror those of GLP-1 agonists: Nausea Diarrhea Decreased appetite Possible gallbladder effects (as with all rapid weight loss) Minimal risk of hypoglycemia when used without insulin Importantly, GIP on its own does not cause hypoglycemia , making it a relatively safe therapeutic target
This is where synthetic modifications like IGF-1 LR3 and IGF-1 DES come into play
This use is not recommended and carries several safety risks , particularly changes in pigment lesions that may mask melanoma
Novo Nordisk's Uphill Battle After Eli Lilly's strong earnings report and promising drug developments, investors will be watching Novo Nordisk carefully when it reports its own Q1 2026 earnings